Balchem price target raised to $189 from $180 at H.C. Wainwright

H.C. Wainwright raised the firm’s price target on Balchem (BCPC) to $189 from $180 and keeps a Buy rating on the shares. The company reported Q2 beat and its future growth should be driven by manufacturing expansion and anti-dumping measures, the analyst tells investors in a research note. The firm believes the European Commission’s provisional anti-dumping duties on imports into the European Union of choline chloride originating in the People’s Republic of China should improve the sales outlook of Balchem’s choline-based products in Europe.